Literature DB >> 10525086

Characterization of interleukin-1alpha binding to mouse brain endothelial cells.

W A Banks1.   

Abstract

In vivo studies have shown that interleukin (IL)-1alpha binds to and is transported across brain endothelial cells, whereas in vitro studies have shown that brain endothelial cells respond to IL and contain mRNA for the IL-type 1 receptor. However, these binding sites have yet to be characterized. Herein, we used murine brain microvessels to characterize the binding of IL labeled with (125)I. Binding was temperature- and time-dependent with maximal binding after 4 h of incubation at 37 degrees C. The amount of radioactivity determined by HPLC to represent intact (125)I-labeled murine IL-1alpha at 4 h was approximately 100% in the incubation fluid and 80 to 90% for radioactive material recovered from the incubated cells. B(max) was 0.955 fmol and the K(d) was 292 pM for human (125)I-IL and binding was displaced by interleukin-1beta and interleukin-1 receptor antagonist but not by tumor necrosis factor alpha. Binding was dependent on magnesium and glucose. Incubation with antibodies showed that the binding site was not identical with the IL-type 1 receptor but closely resembled the blood-brain barrier transporter. These results show that murine brain endothelial cells have specific binding sites for IL and that these sites more closely resemble the transporter than the type 1 receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525086

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

Review 1.  Astrocyte-endothelial interactions and blood-brain barrier permeability.

Authors:  N Joan Abbott
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

2.  IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury.

Authors:  Kathleen Salmeron; Takuma Aihara; Elena Redondo-Castro; Emmanuel Pinteaux; Gregory Bix
Journal:  J Neurochem       Date:  2015-11-27       Impact factor: 5.372

3.  Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke.

Authors:  Kathleen E Salmeron; Michael E Maniskas; Danielle N Edwards; Raymond Wong; Ivana Rajkovic; Amanda Trout; Abir A Rahman; Samantha Hamilton; Justin F Fraser; Emmanuel Pinteaux; Gregory J Bix
Journal:  J Neuroinflammation       Date:  2019-11-14       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.